Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,984 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Expandable progenitors from induced pluripotent stem cells.
Masuda S, Miyagawa S, Fukushima S, Nakamura T, Khurram MA, Ishikawa T, Saito A, Sawa Y. Masuda S, et al. Nat Rev Cardiol. 2016 Oct;13(10):574. doi: 10.1038/nrcardio.2016.129. Epub 2016 Aug 19. Nat Rev Cardiol. 2016. PMID: 27538816 No abstract available.
Eliminating residual iPS cells for safety in clinical application.
Masuda S, Miyagawa S, Fukushima S, Sougawa N, Okimoto K, Tada C, Saito A, Sawa Y. Masuda S, et al. Protein Cell. 2015 Jul;6(7):469-71. doi: 10.1007/s13238-015-0170-4. Protein Cell. 2015. PMID: 26040624 Free PMC article. No abstract available.
Pivotal Role of Non-cardiomyocytes in Electromechanical and Therapeutic Potential of Induced Pluripotent Stem Cell-Derived Engineered Cardiac Tissue.
Iseoka H, Miyagawa S, Fukushima S, Saito A, Masuda S, Yajima S, Ito E, Sougawa N, Takeda M, Harada A, Lee JK, Sawa Y. Iseoka H, et al. Among authors: masuda s. Tissue Eng Part A. 2018 Feb;24(3-4):287-300. doi: 10.1089/ten.TEA.2016.0535. Epub 2017 Jun 13. Tissue Eng Part A. 2018. PMID: 28498040 Free PMC article.
CD30-targeting immunoconjugates and bystander effects.
Masuda S, Miyagawa S, Sougawa N, Sawa Y. Masuda S, et al. Nat Rev Clin Oncol. 2015 Apr;12(4). doi: 10.1038/nrclinonc.2014.159-c1. Epub 2015 Mar 3. Nat Rev Clin Oncol. 2015. PMID: 25734636 No abstract available.
Brentuximab vedotin for CD30-positive tumours.
Masuda S, Miyagawa S, Nakamura T, Khurram MA, Sawa Y. Masuda S, et al. Lancet Oncol. 2016 Sep;17(9):e371. doi: 10.1016/S1470-2045(16)30404-1. Epub 2016 Aug 30. Lancet Oncol. 2016. PMID: 27599139 No abstract available.
1,984 results